Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Marsden

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationMasoud Vedadi, Frank H Niesen, Abdellah Allali-Hassani, et al.
Scientific Data|September 25, 2023
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidityClare E West, Mohd Karim, Maria J Falaguera, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Neurogenetics|March 2, 2026
Expanding the genotypic spectrum of combined oxidative phosphorylation deficiency 54King Lam Lai, Thomas B Smith, Reza Maroofian, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo <i>et al</i>Susan Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Nature Communications|May 16, 2023
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UKJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
BMC Infectious Diseases|February 19, 2021
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infectionsDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Nature Medicine|February 15, 2022
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Koen B Pouwels, Nicole Stoesser, et al.
Nature Communications|June 29, 2022
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infectionJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationMasoud Vedadi, Frank H Niesen, Abdellah Allali-Hassani, et al.
Scientific Data|September 25, 2023
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidityClare E West, Mohd Karim, Maria J Falaguera, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Neurogenetics|March 2, 2026
Expanding the genotypic spectrum of combined oxidative phosphorylation deficiency 54King Lam Lai, Thomas B Smith, Reza Maroofian, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo <i>et al</i>Susan Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Nature Communications|May 16, 2023
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UKJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
BMC Infectious Diseases|February 19, 2021
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infectionsDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Nature Medicine|February 15, 2022
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Koen B Pouwels, Nicole Stoesser, et al.
Nature Communications|June 29, 2022
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infectionJia Wei, Philippa C Matthews, Nicole Stoesser, et al.
Pageof 7